JB Chemicals & Pharmaceuticals Limited — Important, 08-03-2025: Updates

The USFDA has conducted an inspection of J.B. Chemicals & Pharmaceuticals' manufacturing facility T20 in Panoli, Gujarat, from March 3 to March 7, 2025. The audit concluded successfully, with “No Observations” reported, meaning no Form 483 was issued. This outcome reflects the company’s commitment to quality and compliance, highlighting its focus on maintaining high standards through continuous investments in systems and employee training. This positive inspection result reinforces the company's operational stability and commitment to producing quality products, which could enhance investor confidence and support growth strategies moving forward.